Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contribution of inflammatory pathways to Fabry disease pathogenesis
Paula Rozenfeld, Sandro Feriozzi
Molecular Genetics and Metabolism (2017) Vol. 122, Iss. 3, pp. 19-27
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Cardiac Involvement in Fabry Disease
Maurizio Pieroni, James Moon, Eloisa Arbustini, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 7, pp. 922-936
Open Access | Times Cited: 209
Progress in the understanding and treatment of Fabry disease
James J. Miller, Adam J. Kanack, Nancy Dahms
Biochimica et Biophysica Acta (BBA) - General Subjects (2019) Vol. 1864, Iss. 1, pp. 129437-129437
Open Access | Times Cited: 97
Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions
Ken Kok, Kimberley C. Zwiers, Rolf G. Boot, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 271-271
Open Access | Times Cited: 92
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
Karolina M. Stępień, Federico Roncaroli, Nadia Turton, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2596-2596
Open Access | Times Cited: 78
Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease
Dominique P. Germain, Thierry Levade, Eric Hachulla, et al.
Clinical Genetics (2021) Vol. 101, Iss. 4, pp. 390-402
Open Access | Times Cited: 58
Inflammation across the spectrum of hypertrophic cardiac phenotypes
Rosa Lillo, Francesca Graziani, Francesco Franceschi, et al.
Heart Failure Reviews (2023) Vol. 28, Iss. 5, pp. 1065-1075
Open Access | Times Cited: 29
Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations
Raafiah Izhar, Margherita Borriello, Antonella La Russa, et al.
Genes (2023) Vol. 15, Iss. 1, pp. 37-37
Open Access | Times Cited: 25
An expert consensus on the recommendations for the use of biomarkers in Fabry disease
Alessandro P. Burlina, Eva Brand, Derralynn Hughes, et al.
Molecular Genetics and Metabolism (2023) Vol. 139, Iss. 2, pp. 107585-107585
Open Access | Times Cited: 22
Anderson–Fabry disease management: role of the cardiologist
Maurizio Pieroni, Mehdi Namdar, Iacopo Olivotto, et al.
European Heart Journal (2024) Vol. 45, Iss. 16, pp. 1395-1409
Open Access | Times Cited: 13
Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications
Hibba Kurdi, Lucia Lavalle, James Moon, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 10
Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers
Laura López-Valverde, M.E. Vázquez-Mosquera, Cristóbal Colón, et al.
Translational research (2024) Vol. 269, pp. 47-63
Open Access | Times Cited: 8
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases
Margarita M. Ivanova, Erk Changsila, Chidima Iaonou, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210617-e0210617
Open Access | Times Cited: 70
Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease
João B. Augusto, Sabrina Nordin, Ravi Vijapurapu, et al.
Circulation Cardiovascular Imaging (2020) Vol. 13, Iss. 3
Open Access | Times Cited: 69
Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study
Ulla Feldt‐Rasmussen, Derralynn Hughes, Gere Sunder‐Plassmann, et al.
Molecular Genetics and Metabolism (2020) Vol. 131, Iss. 1-2, pp. 219-228
Open Access | Times Cited: 61
Lyso-glycosphingolipids: presence and consequences
Marco van Eijk, Maria J. Ferraz, Rolf G. Boot, et al.
Essays in Biochemistry (2020) Vol. 64, Iss. 3, pp. 565-578
Open Access | Times Cited: 52
Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies
Antonino Tuttolomondo, Irene Simonetta, Renata Riolo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10088-10088
Open Access | Times Cited: 50
Sphingolipid lysosomal storage diseases: from bench to bedside
Muna Abed Rabbo, Yara Khodour, Laurie S. Kaguni, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 42
Fabry disease – a multisystemic disease with gastrointestinal manifestations
Malte Lenders, Eva Brand
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms of Neuroinflammation in Lysosomal Storage Diseases
Manoj K. Pandey
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1067-1067
Open Access | Times Cited: 17
Neuroimaging in Fabry disease: current knowledge and future directions
Sirio Cocozza, Camilla Russo, Giuseppe Pontillo, et al.
Insights into Imaging (2018) Vol. 9, Iss. 6, pp. 1077-1088
Open Access | Times Cited: 49
The Changing Landscape of Fabry Disease
Einar Svarstad, Hans‐Peter Marti
Clinical Journal of the American Society of Nephrology (2020) Vol. 15, Iss. 4, pp. 569-576
Open Access | Times Cited: 49
Corneal confocal microscopy detects corneal nerve damage and increased dendritic cells in Fabry disease
Gülfidan Bitirgen, Kültiğin Türkmen, Rayaz A. Malik, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 47
<p>Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype&ndash;phenotype correlations</p>
João Paulo Oliveira, Susana Ferreira
The Application of Clinical Genetics (2019) Vol. Volume 12, pp. 35-50
Open Access | Times Cited: 45
Fabry disease pain: patient and preclinical parallels
Anthony J. Burand, Cheryl L. Stucky
Pain (2020) Vol. 162, Iss. 5, pp. 1305-1321
Open Access | Times Cited: 45
Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease
Daniel G. Bichet, Johannes M. F. G. Aerts, Christiane Auray‐Blais, et al.
Genetics in Medicine (2020) Vol. 23, Iss. 1, pp. 192-201
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top